S

Sharp HealthCare | Sharp Center for Research

Research site
(Unclaimed)
Location
7930 Frost Street, Suite 300, San Diego, California, United States of America
Site insights

Top conditions

Prostatic Cancer (5 trials)

Cancer (4 trials)

Neoplasm Metastasis (3 trials)

Diffuse Large B-Cell Lymphoma (2 trials)

Fallopian Tube Cancer (2 trials)

Top treatments

Gemcitabine
Docetaxel
Prednisone
Sacituzumab
Milvexian
Ompenaclid
Platinum
Enobosarm
PD-0325901
RCHOP

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

8 of 26
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

The purpose of the study is to evaluate the overall survival of participants treated with imetelstat compared to best available therapy with intermed...

Enrolling
Myelofibrosis
Drug: Imetelstat
Drug: Best Available Therapy (BAT)

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major advers...

Enrolling
Acute Coronary Syndrome
Other: Placebo
Drug: Milvexian

This is a multi-center, open-label study to investigate the safety, efficacy and pharmacokinetics of REC-4881 (12 mg PO daily doses) for the treatmen...

Enrolling
Solid Tumor
APC Gene Mutation
Drug: REC-4881

RGX-202-01 (ompenaclid) is a Phase 1, first-in-human, dose escalation and expansion study of RGX-202-01 as a single agent and in combination with FOL...

Enrolling
Colorectal Carcinoma
KRAS Mutation-Related Tumors
Drug: RGX-202-01
Drug: Bevacizumab

The purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors an...

Active, not recruiting
Solid Tumor
Locally Advanced Solid Tumor
Drug: Niraparib

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic in...

Enrolling
Solid Tumor
Malignant Neoplasm
Drug: nab-sirolimus

The study is a prospective, randomized controlled phase III trial, to test the efficacy, safety and neurocognitive outcomes of advanced NSCLC patient...

Active, not recruiting
Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
Other: Best Standard of Care
Device: NovoTTF-200M device

DF1001-001 is a study of a new molecule that targets natural killer (NK) cells and T-cell activation signals to specific receptors on cancer cells. T...

Enrolling
Solid Tumor, Adult
Drug: Nab paclitaxel
Drug: Nivolumab

Trial sponsors

C

Cell Genesys (2 trials)

Seagen logo

Seagen (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems